Dr. David Fajgenbaum was diagnosed with a rare disorder that killed 35% of patients within five years of diagnosis. Dr. Fajgenbaum realised that he would have to lead the charge against his rare condition and we are talking to this young doctor about his incredible journey unraveling Castleman Disease. Castleman Disease is a rare disease of lymph nodes and related tissues. This is diagnosed in about 5000 people of all ages each year in the United States. This disorder activates the body's immune system, releasing excess inflammatory proteins that can shut down the liver, kidneys and bone marrow. Dr. David Fajgenbaum, Founding Director of the Castleman Disease Center at the University of Pennsylvania discusses the current understanding of the disease that he himself has had nearly for nine years, symptoms, treatment options and explore new trials and research that are in the offing.
Eating disorders (ED) are serious and sometimes fatal illnesses that cause the sufferers to become obsessed with food, body weight and shape, and severely disturb their eating behaviour. Common eating disorders include binge eating disorder, bulimia nervosa, and anorexia nervosa. Recent research around the neurobiology of eating disorders has changed the way we address nourishing ED patients during treatment. Where we once thought of food as a symptom, and only important to prevent death by starvation, we now understand the critical importance of early intervention and full weight restoration. These recommendations challenge old paradigms about the cause and meaning of ED symptoms. This talk with Dr Angela Guarda of Johns Hopkins Hospital, Dr Jennifer Gaudiani and nutritionist Therese Waterhous draws out the role of nourishment from the perspectives of someone with lived experience as well as leading clinicians in the medical and nutritional treatment of these dangerous brain disorders.
Nearly 13000 women are diagnosed with cervical cancer in the United States each year and about 68% of all invasive cervical cancer cases diagnosed involve women of childbearing age. Advanced treatments available today allow women to live longer but the same treatments impact their fertility negatively, decreasing their quality of life severely. This makes it important that these women be given options to preserve their fertility before going for cervical cancer treatments. January is Cervical Cancer awareness month, and in honor we addressed the issue of fertility preservation in cervical cancer patients with Dr Julie Lamb, reproductive endocrinologist and infertility specialist at Pacific NW Fertility in Seattle and clinical faculty at the University of Washington. Morgan and Lauren, Cervical cancer ambassadors for Cervivor.org and Allison Pozzi, a Cervical cancer survivor who successfully built her family via IVF (In vitro fertilisation) also shared their experiences and informed the panel.
Panelists
Dr. Julie Lamb
Morgan S Newman
Allison Pozzi
Lauren Lastauskas
Shweta Mishra
For any of the talks dial-in to 718-664-6574 to participate and ask a question LIVE On-Air! Only 50 callers permitted at one time so HURRY!
What is SOC 2 Compliance? SOC 2 is a voluntary compliance standard for technology companies with cloud-based products and specifies how an organization should manage customer data. The compliance guidelines set by the AICPA (American Institute…
Clinical trial sites, also known as research sites, are facilities where clinical trials are conducted. These sites play a crucial role in the execution of clinical research studies, serving as the primary location for patient enrollment,…
We are thrilled to announce the release of the SAYSTOP Study App for a leading clinical research study investigating antibiotics resistance using TrialX’s remote data collection platform. Investigators at the University of Iowa and UCLA’s Olive…